TD Cowen Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating

Futu NewsDec 21 02:31 · Ratings

Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases

BenzingaDec 19 03:29

Takeda Pharmaceutical (TAK.US) CD38 monoclonal antibody has been approved for clinical use again in China.

Takeda Pharmaceutical's CD38 monoclonal antibody has been approved for clinical use in China again.

Zhitong FinanceDec 17 21:06

6-K: Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas

SECDec 13 19:16 · Announcements

HUTCHMED (China) to Receive $10 Million Milestone Payment From Takeda After First European Reimbursement for Fruzaqla

MT NewswiresDec 13 12:23

Takeda Plans To Host An Investor R&D Day; Expects Six Late-Stage Programs With Peak Revenue Potential Of $10B - $20B To Deliver Sustainable Growth

BenzingaDec 13 06:32